Belgium's OncoDNA believes that IntegraGen's bioinformatics platform will help it manage more cancer patient data and quickly generate patient-specific treatment reports for clinicians.
Belgium-based OncoDNA will purchase France's IntegraGen as part of its plans to provide a solution that combines oncology laboratory testing and bioinformatics software.
The program, which includes OncoDNA, will evaluate the use of molecular diagnostic testing in personalizing treatments for cancer patients in Luxembourg.
Genesis Genome will exclusively make available to physicians in Malaysia OncoDNA's OncoDeep Dx and Clinical cancer panels combined with its Package Plus.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
